Range of suitable clients: CDEC talked over the uncertainty in the volume of people with reasonably significant to significant hemophilia B in Canada qualified for etranacogene dezaparvovec. Clinical professionals consulted by CADTH indicated that some sufferers who're classified as having moderate or reasonable illness may have a severe bleeding p… Read More